Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

被引：211

作者：

Bressi, Jerome C. ^{[1
]}

Jennings, Andy J. ^{[1
]}

Skene, Robert ^{[1
]}

Wu, Yiqin ^{[1
]}

Melkus, Robert ^{[1
]}

De Jong, Ron ^{[1
]}

O'Connell, Shawn ^{[1
]}

Grimshaw, Charles E. ^{[1
]}

Navre, Marc ^{[1
]}

Gangloff, Anthony R. ^{[1
]}

机构：

[1] Takeda San Diego, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 10期

关键词：

Histone deacetylase inhibitors; HDAC; Oncology; HISTONE DEACETYLASE; HYDROXAMIC ACID; INTERNAL CAVITY; INHIBITORS; DESIGN;

D O I：

10.1016/j.bmcl.2010.03.091

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of N-(2-amino-5-substituted phenyl)benzamides (3-21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl) benzamide (6). (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3142 / 3145

页数：4

共 26 条

[1] Isoform-selective histone deacetylase inhibitors
Bieliauskas, Anton V.
Pflum, Mary Kay H.
[J]. CHEMICAL SOCIETY REVIEWS, 2008, 37 (07) : 1402 - 1413
[2] Butler LM, 2000, CANCER RES, V60, P5165
[3] Histone acetylation: a switch between repressive and permissive chromatin - Second in review series on chromatin dynamics
Eberharter, A
Becker, PB
[J]. EMBO REPORTS, 2002, 3 (03) : 224 - 229
[4] Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin M.S.
Donigian J.R.
Cohen A.
Richon V.M.
Rifkind R.A.
Marks P.A.
Breslow R.
Pavletich N.P.
[J]. Nature, 1999, 401 (6749) : 188 - 193
[5] Deacetylase enzymes: biological functions and the use of small-molecule inhibitors
Grozinger, CM
Schreiber, SL
[J]. CHEMISTRY & BIOLOGY, 2002, 9 (01): : 3 - 16
[6] Histone acetylases and deacetylases in cell proliferation
Kouzarides, T
[J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) : 40 - 48
[7] MADELEINE D, 2007, EXPERT OPIN INV DRUG, V16, P1111
[8] Antimalarial and antileishmanial activities of aroyl-pyrrolyl-hydroxyamides, a new class of histone deacetylase inhibitors
Mai, A
Cerbara, I
Valente, S
Massa, S
Walker, LA
Tekwani, BL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1435 - 1436
[9] Histone deacetylase inhibitors as new cancer drugs
Marks, PA
Richon, VM
Breslow, R
Rifkind, RA
[J]. CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) : 477 - 483
[10] Histone deacetylases and cancer: Causes and therapies
Marks, PA
Rifkind, RA
Richon, VM
Breslow, R
Miller, T
Kelly, WK
[J]. NATURE REVIEWS CANCER, 2001, 1 (03) : 194 - 202

← 1 2 3 →